Loading...
Advances in gout: some answers, more questions
In a previous issue of the journal, Becker and colleagues present efficacy and safety data from a large study comparing febuxostat to allopurinol. The study showed non-inferiority of febuxostat 40 mg/day in lowering serum urate compared to allopurinol 200 to 300 mg/day. More importantly, the study s...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2990989/ https://ncbi.nlm.nih.gov/pubmed/20959031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar3110 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|